Health Professional Radio - Podcast

Spiro Rombotis, President and CEO of Cyclacel Pharmaceuticals, a developer of novel therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases, discusses 3 programs currently in the pipeline for the treatment of various cancers; a transcriptional regulation program, a mitosis regulation program, and a DNA damage response program.